The Wesfarmers Ltd (ASX:WES) share price and Resmed CDI (ASX:RMD) share price are worth watching
Rask Invest Research Team
August 12, 2024
The Wesfarmers Ltd (ASX:WES) share price has risen 23.5% since
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The Wesfarmers Ltd (ASX:WES) share price has risen 23.5% since
The Resmed CDI (ASX:RMD) share price is up 28.6% since
The Wesfarmers Ltd (ASX:WES) share price has jumped 24.2% since
The Resmed CDI (ASX:RMD) share price has risen 27.8% since
The Resmed CDI (ASX:RMD) share price is up 32.3% since
The CSL Ltd (ASX:CSL) share price has risen 4.9% since
The Resmed Inc (ASX:RMD) share price is under the spotlight
The Resmed CDI (ASX:RMD) share price has risen 23.9% since
The Rea Group Ltd (ASX:REA) share price has jumped 6.4%
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.